Stock Scorecard



Stock Summary for Arcus Biosciences Inc (RCUS) - $18.88 as of 3/28/2024 9:59:57 PM EST

Total Score

9 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for RCUS

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for RCUS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for RCUS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for RCUS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for RCUS

Stocks Generating Improved Relative Strength: Arcus Biosciences 2/27/2024 8:00:00 AM
Wall Street Analysts Think Arcus Biosciences, Inc. ( RCUS ) Could Surge 151.61%: Read This Before Placing a Bet 2/22/2024 2:55:00 PM
C4 Therapeutics ( CCCC ) to Report Q4 Earnings: What's in Store? 2/15/2024 3:19:00 PM
INCY: Elite 4 Biotech Stocks to Buy Now for Explosive Returns 2/13/2024 1:54:00 PM
4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip 2/10/2024 10:06:00 AM
Exelixis ( EXEL ) Q4 Earnings Beat on Lower R&D Spend, Sales Miss 2/7/2024 6:13:00 PM
$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying - Peoples Financial ( OTC:PFBX ) , Amrep ( NYSE:AXR ) 2/1/2024 11:09:00 AM
Bitcoin, Ethereum, Dogecoin Rise As Crypto Shorts Face Liquidations?; Meta Gets 22% Price Target Boost Ahead Of Q4 Results As Analyst Pins Hopes On Ad Market Recovery, Reels Strength - Top Headlines Today While US Was Sleeping 1/30/2024 2:32:00 PM
Why Is Arcus Biosciences Stock Trading Higher Today? - Arcus Biosciences ( NYSE:RCUS ) , Gilead Sciences ( NASDAQ:GILD ) 1/30/2024 11:27:00 AM
Microsoft, UPS, GM, Pfizer, Super Micro Computer, Calix, Sanmina, and More Stock Market Movers 1/30/2024 9:25:00 AM

Financial Details for RCUS

Company Overview

Ticker RCUS
Company Name Arcus Biosciences Inc
Country USA
Description Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States. The company is headquartered in Hayward, California.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 12/31/2023
Next Earnings Date 5/7/2024

Stock Price History

Last Day Price 18.88
Last Day Price Updated 3/28/2024 9:59:57 PM EST
Last Day Volume 744,390
Average Daily Volume 946,963
52-Week High 25.47
52-Week Low 12.95
Last Price to 52 Week Low 45.79%

Valuation Measures

Trailing PE N/A
Industry PE 100.07
Sector PE 60.76
5-Year Average PE 13.54
Free Cash Flow Ratio 2.26
Industry Free Cash Flow Ratio 12.70
Sector Free Cash Flow Ratio 31.04
Current Ratio Most Recent Quarter 4.52
Total Cash Per Share 8.35
Book Value Per Share Most Recent Quarter 6.12
Price to Book Ratio 3.24
Industry Price to Book Ratio 5.57
Sector Price to Book Ratio 21.66
Price to Sales Ratio Twelve Trailing Months 12.79
Industry Price to Sales Ratio Twelve Trailing Months 13.94
Sector Price to Sales Ratio Twelve Trailing Months 8.77

Share Statistics

Total Shares Outstanding 90,865,000
Market Capitalization 1,715,531,200
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -14.98%
Reported EPS 12 Trailing Months -4.15
Reported EPS Past Year -4.15
Reported EPS Prior Year -3.72
Net Income Twelve Trailing Months -307,000,000
Net Income Past Year -307,000,000
Net Income Prior Year -267,000,000
Quarterly Revenue Growth YOY -8.80%
5-Year Revenue Growth 69.54%

Balance Sheet

Total Cash Most Recent Quarter 759,000,000
Total Cash Past Year 759,000,000
Total Cash Prior Year 1,009,000,000
Net Cash Position Most Recent Quarter 759,000,000
Net Cash Position Past Year 759,000,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 462,000,000
Total Stockholder Equity Prior Year 657,000,000
Total Stockholder Equity Most Recent Quarter 462,000,000

Options

Put/Call Ratio 0.30
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.12
MACD Signal 0.39
20-Day Bollinger Lower Band 13.20
20-Day Bollinger Middle Band 16.77
20-Day Bollinger Upper Band 20.34
Beta 0.81
RSI 46.54
50-Day SMA 18.23
200-Day SMA 25.81

System

Modified 3/27/2024 5:21:10 AM EST